CORE-ABR
Sales sheet Request a demo

Pathogen

Candida glabrata / tropicalis

Non-albicans Candida species. C. glabrata (now Nakaseomyces glabratus) often shows reduced susceptibility to fluconazole.

Also: Nakaseomyces glabratus

FungiUTI panelWound panelSTI panelIdentified · not antibiotic-graded

On the report

A fungus, so the antibacterial grid does not apply. The summary flags the species-level antifungal considerations.

What the report shows for Candida glabrata / tropicalis

  • Detected or not detected, with Ct, limit of detection and cycles above LOD — see PCR reporting.
  • A short pathogen summary, including colonizer likelihood where it applies.
  • No antibacterial grades — the report identifies the organism and points to guideline management instead.
  • When not detected, it is still listed among targets tested.

Tagged

Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.